TGA Issues Safety Alert for Counterfeit GLP-1 Weight Loss Products
The Therapeutic Goods Administration (TGA) has confirmed that imported weight loss products claiming to contain GLP-1 are counterfeit following laboratory testing.
What Happened
The Therapeutic Goods Administration (TGA) has issued an updated safety advisory after laboratory testing confirmed that certain imported weight loss products are counterfeit. These products falsely claim to contain GLP-1 (glucagon-like peptide-1) receptor agonists.
Which Products Are Affected
The alert concerns counterfeit imported weight loss products marketed as containing GLP-1. While specific brand names were not detailed in the summary, the TGA identifies these as imported goods that have been tested and found to be fraudulent versions of weight loss medications.
What You Should Do
Consumers are urged to stop using any imported weight loss products that claim to contain GLP-1. Because these products are counterfeit, their safety, quality, and efficacy are entirely unknown. If you have purchased these products, you should dispose of them and consult a healthcare professional if you have concerns about your health.
Why This Matters
Counterfeit medications pose a significant health risk because they bypass regulatory oversight and may contain dangerous undeclared ingredients, incorrect dosages, or harmful contaminants.
Source
Source: TGA Official Notice